All Stories

  1. Uniformity in air trapping distribution is associated with the severity of airway hyper-responsiveness in asthma
  2. Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial
  3. Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5‐Year National Cohort Analysis
  4. Occupational exposure to aerosols in two French airports: multi-year lung function changes
  5. Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosis
  6. Emission Characteristics and Potential Exposure Assessment of Aerosols and Ultrafine Particles at Two French Airports
  7. Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis
  8. Change in cardiorespiratory parameters following surgical correction of pectus excavatum: protocol for the historical-prospective HeartSoar cohort
  9. Airway epithelial type‐2 alarmin profiles: Blood eosinophil counts remain in memory
  10. Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
  11. Standard patient training versus Vik-Asthme chatbot-guided training: ‘AsthmaTrain’ – a protocol for a randomised controlled trial for patients with asthma
  12. Obesity in women with asthma: Baseline disadvantage plus greater small‐airway responsiveness
  13. Rheology predicts sputum eosinophilia in patients with muco-obstructive lung diseases
  14. Change in incidence of cardiovascular diseases during the covid-19 pandemic and vaccination campaign: data from the nationwide French hospital discharge database
  15. Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea
  16. Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial
  17. Complication and lung function impairment prediction using perfusion and computed tomography air trapping (CLIPPCAIR): protocol for the development and validation of a novel multivariable model for the prediction of post-resection lung function
  18. Association between increased mortality and bronchial fibroscopy in intensive care units and intermediate care units during COPD exacerbations: an analysis of the 2014 and 2015 National French Medical-based Information System Databases (PMSI)
  19. Sacubitril‐valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO‐SAS study
  20. Apnoea–hypopnoea indices determined via continuous positive airway pressure (AHI-CPAPflow) versus those determined by polysomnography (AHI-PSGgold): a protocol for a systematic review ...
  21. Health-related quality of life and disease progression in PAH patients: a 3-year study
  22. Third generation cognitive behavioural therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a randomized, 2-parallel-group, evaluator blinded, superiority trial
  23. “Real-life” management of patients with severe asthma in the biologics era: Can we do better?
  24. Étude vie réelle multicentrique des réglages de la ventilation auto-asservie : faire attention aux volumes générés !
  25. Club Cell Loss as a Feature of Bronchiolization in ILD
  26. Tapering of Oral Corticosteroids for the Treatment of Asthma
  27. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study
  28. Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study
  29. Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2
  30. Will the asthma revolution fostered by biologics also benefit adult ICU patients?
  31. Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma: A Delphi Study
  32. Transbronchial cryobiopsy in the diagnosis of interstitial lung diseases: methodologies and perspectives from the Cryo-PID and COLDICE studies
  33. Patterns of adaptive servo-ventilation settings in a real-life multicenter study: pay attention to volume!
  34. Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
  35. Management of sleep apnoea syndrome (SAS) in patients with vasovagal syncope (VVS): a protocol for the VVS-SAS cohort study
  36. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
  37. PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy
  38. Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
  39. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
  40. Feasibility of type 3 polygraphy for evaluating leak determinants in CPAP-treated OSA patients: a step towards personalized leak management
  41. Usual care including home exercise with versus without spa therapy for chronic low back pain: protocol for the LOMBATHERM’ study, a multicentric randomised controlled trial
  42. Careful consideration of the bleeding caused by transbronchial lung cryobiopsies
  43. Asthma rescue treatments, time to reboot
  44. Reply to Wand et al.: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale
  45. Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship
  46. What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study)
  47. Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al.
  48. Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients?
  49. k-Nearest Neighbor Curves in Imaging Data Classification
  50. Poor Concordance of Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in ILDs
  51. CCSP counterbalances airway epithelial-driven neutrophilic chemotaxis
  52. Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials
  53. Goblet cell hyperplasia as a feature of neutrophilic asthma
  54. Randomised controlled trials in severe asthma: selection by phenotype or stereotype
  55. Residual excessive sleepiness in long term CPAP-treated patients: a leak problem?
  56. Thoughts on entering correlated imaging variables into a multivariable model: Application to radiomics and texture analysis
  57. Asthma, COPD, and overlap in a national cohort: ACO on a gradient
  58. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension
  59. The feasibility of a mandibular movement test as a screening tool for polysomnography candidates
  60. Mortality: a neglected outcome in OCS-treated severe asthma
  61. Profiling the biological effects of wastewater samples via bioluminescent bacterial biosensors combined with estrogenic assays
  62. Computerized Medico-Economic Decision Making: An International Comparison
  63. Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock
  64. An Increase in Aortic Blood Flow after an Infusion of 100 ml Colloid over 1 Minute Can Predict Fluid Responsiveness
  65. Disagreement between pulse contour analysis and transpulmonary thermodilution for cardiac output monitoring after routine therapeutic interventions in ICU patients with acute circulatory failure
  66. Unexpected morphological and karyological changes in invasive Carpobrotus (Aizoaceae) in Provence (S-E France) compared to native South African species
  67. Consistency in the habitat degree of invasion for three invasive plant species across Mediterranean islands
  68. Release from soil pathogens plays an important role in the success of invasive Carpobrotus in the Mediterranean
  69. Widespread resistance of Mediterranean island ecosystems to the establishment of three alien species
  70. Consistent performance of invasive plant species within and among islands of the Mediterranean basin
  71. Floral Chemical Signatures in the Genus Ophrys L. (Orchidaceae): A Preliminary Test of a New Tool for Taxonomy and Evolution
  72. The evolutionary potential of invasive Carpobrotus (Aizoaceae) taxa: are pollen-mediated gene flow potential and hybrid vigor levels connected?
  73. Local and regional assessments of the impacts of plant invaders on vegetation structure and soil properties of Mediterranean islands
  74. Unexpected insularity effects in invasive plant mating systems: the case of Carpobrotus (Aizoaceae) taxa in the Mediterranean Basin
  75. Invasional meltdown potential: Facilitation between introduced plants and mammals on French Mediterranean islands
  76. Invasion dynamics of two alien Carpobrotus (Aizoaceae) taxa on a Mediterranean island: II. Reproductive strategies
  77. Invasion dynamics of two alien Carpobrotus (Aizoaceae) taxa on a Mediterranean island: I. Genetic diversity and introgression
  78. Asthma: treatment and prevention of pulmonary exacerbations